Simultaneous production of rhamnolipids, 2-alkyl-4-hydroxyquinolines, and phenazines by clinical isolates of Pseudomonas aeruginosa.
AUTOR(ES)
Smeal, B C
RESUMO
Of 72 clinical isolates of Pseudomonas aeruginosa examined for simultaneous production of secondary metabolites, 86% produced 2-alkyl-4-hydroxyquinolines, 75% produced rhamnolipids, and 58% produced phenazines, including pyocyanin. Whereas isolates producing two or one constituted smaller groups, 39% released all three metabolites. Metabolite production did not appear to influence site of infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=269200Documentos Relacionados
- Exotoxin production by clinical isolates of pseudomonas aeruginosa.
- Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
- Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
- Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa.
- Cyanide production by Pseudomonas fluorescens and Pseudomonas aeruginosa.
